Long-term efficacy of immune checkpoint inhibitors in advanced NSCLC: challenges and opportunities—a commentary of the 3-year follow-up of the KEYNOTE-001 trial

Detalles Bibliográficos
Autores principales: Russo, Alessandro, Scilla, Katherine A., Rolfo, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797642/
https://www.ncbi.nlm.nih.gov/pubmed/35117140
http://dx.doi.org/10.21037/tcr.2019.06.24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797642/
https://www.ncbi.nlm.nih.gov/pubmed/35117140
http://dx.doi.org/10.21037/tcr.2019.06.24

Ejemplares similares